ReoPro: Enrollment in the 100-patient U.S. Prolog trial is near completion. Data will be presented at the American Heart Association meeting in November.

Centocor Inc. (CNTO), Malvern, Penn. Product: ReoPro, monoclonal antibody targeted at GP IIb/IIIa Indication: Weight-adjusted heparin safety study Status: Enrollment in the 100-patient U.S. Prolog tr...